Request Sample Inquiry
Dermal Fillers Market

Dermal Fillers Market

Dermal Fillers Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

144

Base Year:

2021

Date

Aug - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1793

Segments Covered
  • By Product Biodegradable, Non-Biodegradable
  • By Material Type Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres, Other Material Types
  • By Application Facial Line Correction, Face Lift, Lip Enhancement, Other Applications
  • By End-Use Dermatology Clinics, Hospitals, Other End Uses
  • By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: USD 4.7 Billion
Revenue 2028Revenue 2028: USD 7.9 Billion
Revenue CAGRRevenue CAGR (2022 - 2028): 9.2%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Dermal Fillers Market Share

Market Synopsis:

The Global Dermal Fillers Market was valued at USD 4.7 Billion in the year 2021 and is projected to reach a value of USD 7.9 Billion by the year 2028. The Global Market is anticipated to grow to exhibit a Compound Annual Growth Rate (CAGR) of 9.2% over the forecast period.

The need for cosmetic procedures has grown significantly and steadily in the contemporary environment, remarkably non-invasive cosmetic procedures like dermal fillers. To obtain an attractive result, these gel-like substances are injected beneath the skin of the face. With rising disposable income across the board, especially in emerging economies, it is projected that the prevalence of these treatments will increase. Additionally, as more individuals become aware of filler procedures, the remaining taboos around cosmetic procedures have significantly decreased. The use of these items is anticipated to increase dramatically due to these changes in attitudes.

Dermal Fillers Market Size, 2021 To 2028 (USD Billion)

The sharp rise in demand for facial aesthetics is one of the essential critical factors for the global industry. People have recently sought more straightforward and painless procedures for a youthful appearance and healthy visage. Since invasive cosmetic procedures frequently have many dangers and require the patient to take extra time to recover from the system. Despite various aesthetic applications, several restrictions are anticipated to impede the expansion of the global market during the expected time. One of the main obstacles preventing the fall in expanding the global market is the high cost of these products.

Market Segmentation:

The Dermal Fillers market is segmented based on Product type, Material Type, Application, End-Use, and Region. Based on Product Type, the market is further segmented into Biodegradable and Non-biodegradable. Furthermore, based on Material Type, the market is further divided into Hyaluronic Acid (HA), Calcium Hydroxylapatite {CaHA}, Poly-L-lactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), and Other Material Types. Likewise, based on the Application segment, the market is classified into Face Line Correction, Facelift, Lip Enhancement, and Other Applications. Furthermore, based on the End-Use, the market is further segmented into Dermatology Clinics, Hospitals, and Other End Uses.

Below tree is interactive. You can click the nodes to get more information.

Based on Product Types:

The Biodegradable sector is anticipated to have a more significant market share in 2021 and to grow faster than other segments over the forecast period. Collagens, Hyaluronic Acids (hyaluronic), hydroxylapatite, poly-l-lactic acid (PLLA), and cadaveric tissue are Biodegradable Dermal Fillers. These goods have FDA approval and are secure. JUVÉDERM VOLUMA XC is a viscoelastic, clear, colorless, and homogenized gel implant that is sterile, biodegradable, non-pyrogenic, and marketed by Allergan PLC. The FDA approved JUVÉDERM VOLUMA XC for chin enhancement in June 2020.

Based on Application:

The Facial Line Correction treatment segment will likely hold the market's most significant share in 2021. In contrast, the Facelift segment is estimated to register the highest Compound Annual Growth Rate (CAGR) in the market during the forecast period. During the forecast period, demand for Dermal Fillers is also expected to expand due to rising consumer awareness of the advantages of Dermal Fillers and rising healthcare spending on non-surgical aesthetic procedures.

North America had a Major Share and is projected to continue its Dominance over the Forecast Period

North America is expected to dominate throughout the forecast period. As a result, the region is also anticipated to hold the dominant dermal fillers market share during the forecast period. A few aspects of this region's domination comprise an incredibly conscious and financially steady population. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2020, about 15.6 million cosmetic procedures were formed in the U.S. Furthermore, regulatory approvals and new product launches are also expected to drive the region’s growth in the forecast period.

Europe is predicted to hold the second highest market share, which is accredited to the growing inclination amongst individuals to experience Dermal Fillers processes in critical European nations and increasing expenditure on R&D in Europe. However, the Asia Pacific is projected to perceive a tremendous growth rate during the forecast period. The enhancement in healthcare infrastructure in Asian nations, the surging aging population, and the growing awareness of individuals concerning their physical presence are fuelling the market growth in the region.

Competitive Landscape:

The key players in the Global Dermal Fillers Market include- AbbVie Inc. (Allergan), Merz Pharma GmbH & Co. KGaA., Galderma S.A, Croma Pharma GmbH., Cytophil Inc., Huons Global Co. Ltd. (Humedix), Prollenium Medical Technologies, Shanghai Bioha Technology Co. Ltd, Sinclair Pharma, Teoxane Laboratories, Zhejiang Jingjia Medical Technology Co. Ltd. and others.

Segmentation of the Global Dermal Fillers Market:

Parameter Details
Segments Covered
  • Product (Biodegradable, Non-Biodegradable)
  • Material Type (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres, Other Material Types)
  • Application (Facial Line Correction, Face Lift, Lip Enhancement, Other Applications)
  • End-Use (Dermatology Clinics, Hospitals, Other End Uses)
  • Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • AbbVie Inc. (Allergan)
  • Merz Pharma GmbH & Co. KGaA.
  • Galderma S.A
  • Croma Pharma GmbH.
  • Cytophil Inc.
  • Huons Global Co. Ltd. (Humedix)
  • Prollenium Medical Technologies
  • Shanghai Bioha Technology Co. Ltd
  • Sinclair Pharma
  • Teoxane Laboratories
  • Zhejiang Jingjia Medical Technology Co. Ltd.
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Dermal Fillers Market to Reach Valuation of USD 7.9 Billion by 2028 – Increasing Research and Development (R&D) Initiatives Drives the Market
In terms of revenue, the Global Dermal Fillers Market is expected to reach USD 7.9 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 9.2% from 2022 to 2028. The increasing awareness about aesthetic beauty, increasing aesthetic beauty requirement because of its benefits, growing i...
FAQ
Frequently Asked Question
  • The global Dermal Fillers valued at USD 4.7 Billion in 2020 and is expected to reach USD 7.9 Billion in 2028 growing at a CAGR of 9.2%.

  • The prominent players in the market are AbbVie Inc. (Allergan), Merz Pharma GmbH & Co. KGaA., Galderma S.A, Croma Pharma GmbH., Cytophil Inc., Huons Global Co. Ltd. (Humedix), Prollenium Medical Technologies, Shanghai Bioha Technology Co. Ltd, Sinclair Pharma, Teoxane Laboratories, Zhejiang Jingjia Medical Technology Co. Ltd..

  • The market is project to grow at a CAGR of 9.2% between 2021 and 2028.

  • The driving factors of the Dermal Fillers include

    • Rising Demand for Anti-Aging Procedures

  • North America was the leading regional segment of the Dermal Fillers in 2020.